PRECOSE Drug Patent Profile

✉ Email this page to a colleague

Which patents cover Precose, and what generic alternatives are available?

Precose is a drug marketed by Bayer Hlthcare and is included in one NDA.

The generic ingredient in PRECOSE is acarbose. There are six drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the acarbose profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Precose

A generic version of PRECOSE was approved as acarbose by HIKMA on May 7^th, 2008.

Try a Trial

Summary for PRECOSE

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	28
Clinical Trials:	8
Patent Applications:	7,469
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for PRECOSE
What excipients (inactive ingredients) are in PRECOSE?	PRECOSE excipients list
DailyMed Link:	PRECOSE at DailyMed

Drug patent expirations by year for PRECOSE

Recent Clinical Trials for PRECOSE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Montefiore Medical Center	Phase 2
Zhongda Hospital	Phase 4
University of British Columbia	Phase 2

See all PRECOSE clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for PRECOSE

A10BF	Alpha glucosidase inhibitors
A10B	BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
A10	DRUGS USED IN DIABETES
A	Alimentary tract and metabolism

Paragraph IV (Patent) Challenges for PRECOSE

Tradename	Dosage	Ingredient	Strength	NDA	ANDAs Submitted	Submissiondate
PRECOSE	Tablets	acarbose	25 mg, 50 mg and 100 mg	020482	1	2005-03-22

US Patents and Regulatory Information for PRECOSE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Bayer Hlthcare	PRECOSE	acarbose	TABLET;ORAL	020482-004	May 29, 1997		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Bayer Hlthcare	PRECOSE	acarbose	TABLET;ORAL	020482-001	Sep 6, 1995		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Bayer Hlthcare	PRECOSE	acarbose	TABLET;ORAL	020482-002	Sep 6, 1995		DISCN	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for PRECOSE

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Bayer Hlthcare	PRECOSE	acarbose	TABLET;ORAL	020482-002	Sep 6, 1995	⤷ Try a Trial	⤷ Try a Trial
Bayer Hlthcare	PRECOSE	acarbose	TABLET;ORAL	020482-004	May 29, 1997	⤷ Try a Trial	⤷ Try a Trial
Bayer Hlthcare	PRECOSE	acarbose	TABLET;ORAL	020482-001	Sep 6, 1995	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for PRECOSE

See the table below for patents covering PRECOSE around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
Spain	2038591		⤷ Try a Trial
Hungary	T43083		⤷ Try a Trial
Japan	2628853		⤷ Try a Trial
European Patent Office	0226121	COMPOSITION CONTAINING VERY PURE ACARBOSE	⤷ Try a Trial
Bulgaria	49497	METHOD FOR PREPARING AKARBOZA	⤷ Try a Trial
Japan	H08245683	CHEMICAL COMPOSITION	⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Summary for PRECOSE

Recent Clinical Trials for PRECOSE

Anatomical Therapeutic Chemical (ATC) Classes for PRECOSE

Paragraph IV (Patent) Challenges for PRECOSE

Make Better Decisions: Try a trial or see plans & pricing